These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 2109870
1. [Effects of verapamil and disopyramide phosphate on the termination, reinduction and long-term prevention of paroxysmal supraventricular tachycardia]. Tsuchioka Y, Nakagawa H, Yamagata T, Sakura E, Hashimoto M, Okamoto M, Matsuura H, Kajiyama G. Kokyu To Junkan; 1990 Mar; 38(3):243-8. PubMed ID: 2109870 [Abstract] [Full Text] [Related]
2. Comparative clinical and electrophysiologic effects of adenosine and verapamil on termination of paroxysmal supraventricular tachycardia. Sethi KK, Singh B, Kalra GS, Arora R, Khalilullah M. Indian Heart J; 1994 Mar; 46(3):141-4. PubMed ID: 7821934 [Abstract] [Full Text] [Related]
10. Comparison of efficacy of intravenous diltiazem and esmolol in terminating supraventricular tachycardia. Gupta A, Naik A, Vora A, Lokhandwala Y. J Assoc Physicians India; 1999 Oct; 47(10):969-72. PubMed ID: 10778689 [Abstract] [Full Text] [Related]
12. [Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia]. Musto B, D'Onofrio A, Cavallaro C, Musto A, Della Gatta O, Marsico F. G Ital Cardiol; 1987 May; 17(5):444-9. PubMed ID: 3115857 [Abstract] [Full Text] [Related]
13. [Mechanism of the alternation cycle length phenomenon during intravenous verapamil for termination of atrioventricular reciprocating tachycardia]. Du RY, Zhang NZ. Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Apr; 21(2):85-6, 122-3. PubMed ID: 8223169 [Abstract] [Full Text] [Related]
14. Acute and chronic effects of verapamil in patients with paroxysmal supraventricular tachycardia. Sakurai M, Yasuda H, Kato N, Nomura A, Fujita M, Nishino T, Fujita K, Koike Y, Saito H. Am Heart J; 1983 Apr; 105(4):619-28. PubMed ID: 6837416 [Abstract] [Full Text] [Related]
16. Comparative analysis of electrophysiologic effect of metoprolol and disopyramide, acting alone or in combination in patients with supraventricular tachycardia and Wolff-Parkinson-White syndrome. Bobrov VA, Frolov AI, Mitchenko EI, Galichansky IV, Zinchenko YuV. Rev Port Cardiol; 1994 Mar; 13(3):221-5. PubMed ID: 8049089 [Abstract] [Full Text] [Related]
17. [Efficacy and safety of adenosine triphosphate in the control of supraventricular paroxysmal tachycardia]. Brandão L, de Sousa J, Barreiros MC, Vagueiro MC, Amram SS. Rev Port Cardiol; 1994 Mar; 13(3):197-202, 191. PubMed ID: 8049086 [Abstract] [Full Text] [Related]
18. Usefulness of invasive and non-invasive electrophysiologic studies in the selection of antiarrhythmic drugs for the patients with paroxysmal supraventricular tachyarrhythmia. Satake S, Hiejima K, Moroi Y, Hirao K, Kubo I, Suzuki F, Suzuki F. Jpn Circ J; 1985 Mar; 49(3):345-50. PubMed ID: 3981793 [Abstract] [Full Text] [Related]
19. [Electrophysiologic effect of sotalol in supraventricular tachycardias]. Borggrefe M, Breithardt G. Z Kardiol; 1985 Sep; 74(9):506-11. PubMed ID: 4060828 [Abstract] [Full Text] [Related]
20. Intravenous tetrandrine in terminating acute episodes of paroxysmal supraventricular tachycardia. Dai GZ, Zeng B, Zhang YL, Lu YX. Chin Med J (Engl); 1990 Jun; 103(6):460-3. PubMed ID: 2119958 [Abstract] [Full Text] [Related] Page: [Next] [New Search]